Litigation Details for Glaxo Group Ltd. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Glaxo Group Ltd. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-12-27 |
| Court | District Court, D. Delaware | Date Terminated | 2018-02-06 |
| Cause | 35:271 Patent Infringement | Assigned To | Vacant Judgeship |
| Jury Demand | None | Referred To | Sherry R. Fallon |
| Patents | 8,637,512; 9,144,547 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Glaxo Group Ltd. v. Aurobindo Pharma USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Glaxo Group Ltd. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-12-26 | 1 | is an action for patent infringement of U.S. Patent No. 8,637,512 (“the ’512 patent,” attached as Exhibit… U.S. Patent No. 9,144,547, (“the ’547 patent,” attached as Exhibit B) arising under the patent laws … PATENTS-IN-SUIT The ‘512 Patent 11. GSK is …of the ’512 patent, entitled “Formulations and Method of Treatment,” which the U.S. Patent and Trademark… the ’512 patent is attached hereto as Exhibit A. 12. The ’512 patent discloses | External link to document | |
| 2017-12-26 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,637,512 B2; US 9,144,547 …2017 6 February 2018 1:17-cv-01862 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2018-02-05 | 7 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,637,512 B2; US 9,144,547 …2017 6 February 2018 1:17-cv-01862 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
